Document is current
Any future updates will be listed below
-
Authors
Burns, Gully
Kauffman, Carey
Manion, Michele
Pai, Ruth-Anne
Milla, Carlos
O’Connor, Michael G.
Shapiro, Adam J.
Bjornson-Pennell, Heidi https://orcid.org/0009-0001-4106-7151
-
Funding
Funding for this research was provided by:
NHLBI Division of Intramural Research (U54HL096458, 1U01HL172658-01)
- License Information
-
More Information
Article History
Received: 15 May 2025
Accepted: 30 July 2025
First Online: 14 October 2025
Declarations
:
: Institutional Review Board: Protocol number PCDFR001 approved by the Genetic Alliance Institutional Review Board. This study was not registered.
: Not applicable.
: Dr. Shapiro is a member of the Advisory Boards for the Primary Ciliary Dyskinesia Foundation, Parion Sciences, Ethris GmbH, and ReCode Therapeutics. He receives salary support from the Primary Ciliary Dyskinesia Foundation and grant funding from the Chest Foundation and the National Institutes of Health.
